Innate Immune Cells in Inflammation and Cancer

The innate immune system has evolved in multicellular organisms to detect and respond to situations that compromise tissue homeostasis. It comprises a set of tissue-resident and circulating leukocytes primarily designed to sense pathogens and tissue damage through hardwired receptors and eliminate noxious sources by mediating inflammatory processes. While indispensable to immunity, the inflammatory mediators produced in situ by activated innate cells during injury or infection are also associated with increased cancer risk and tumorigenesis. Here, we outline basic principles of innate immune cell functions in inflammation and discuss how these functions converge upon cancer development. Cancer Immunol Res; 1(2); 77–84. ©2013 AACR.

[1]  F. Bushman,et al.  Innate lymphoid cells regulate CD4+ T cell responses to intestinal commensal bacteria , 2013, Nature.

[2]  M. Merad,et al.  Interleukin-22 binding protein (IL-22BP) is constitutively expressed by a subset of conventional dendritic cells and is strongly induced by retinoic acid , 2013, Mucosal Immunology.

[3]  F. Powrie,et al.  Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model , 2013, The Journal of experimental medicine.

[4]  J. Pollard,et al.  Macrophage biology in development, homeostasis and disease , 2013, Nature.

[5]  Yongzhong Liu,et al.  Elevated serum IL-22 levels correlate with chemoresistant condition of colorectal cancer. , 2013, Clinical immunology.

[6]  Xuehao Wang,et al.  IL-22 is related to development of human colon cancer by activation of STAT3 , 2013, BMC Cancer.

[7]  R. Locksley,et al.  Innate lymphoid cells — a proposal for uniform nomenclature , 2013, Nature Reviews Immunology.

[8]  C. Datz,et al.  Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth , 2012, Nature.

[9]  Amin R. Mazloom,et al.  Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages , 2012, Nature Immunology.

[10]  Francis J. Huber,et al.  IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine , 2012, Nature.

[11]  R. Jenq,et al.  Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease. , 2012, Immunity.

[12]  Daniel N. Wilson,et al.  The structure and function of the eukaryotic ribosome. , 2012, Cold Spring Harbor perspectives in biology.

[13]  J. Pollard,et al.  A Lineage of Myeloid Cells Independent of Myb and Hematopoietic Stem Cells , 2012, Science.

[14]  M. Manz,et al.  Demand-adapted regulation of early hematopoiesis in infection and inflammation. , 2012, Blood.

[15]  Hergen Spits,et al.  Innate lymphoid cells: emerging insights in development, lineage relationships, and function. , 2012, Annual review of immunology.

[16]  R. Steinman.  Decisions about dendritic cells: past, present, and future. , 2012, Annual review of immunology.

[17]  D. Gabrilovich,et al.  Coordinated regulation of myeloid cells by tumours , 2012, Nature Reviews Immunology.

[18]  L. Zitvogel,et al.  Inflammasomes in carcinogenesis and anticancer immune responses , 2012, Nature Immunology.

[19]  V. Dixit,et al.  Signaling in innate immunity and inflammation. , 2012, Cold Spring Harbor perspectives in biology.

[20]  T. Hohl,et al.  Interleukin 23 production by intestinal CD103(+)CD11b(+) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense. , 2012, Immunity.

[21]  E. Mardis,et al.  Cancer Exome Analysis Reveals a T Cell Dependent Mechanism of Cancer Immunoediting , 2012, Nature.

[22]  Richard A. Flavell,et al.  Inflammasomes in health and disease , 2012, Nature.

[23]  S. Galli,et al.  Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils , 2011, Nature Immunology.

[24]  Alberto Mantovani,et al.  Neutrophils in the activation and regulation of innate and adaptive immunity , 2011, Nature Reviews Immunology.

[25]  F. Finkelman,et al.  Local Macrophage Proliferation, Rather than Recruitment from the Blood, Is a Signature of TH2 Inflammation , 2011, Science.

[26]  S. Travis,et al.  IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease , 2011, The Journal of experimental medicine.

[27]  Y. Wan,et al.  Memory/effector (CD45RBlo) CD4 T cells are controlled directly by IL-10 and cause IL-22–dependent intestinal pathology , 2011, The Journal of experimental medicine.

[28]  R. Schreiber,et al.  Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion , 2011, Science.

[29]  Drew A. Torigian,et al.  CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans , 2011, Science.

[30]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[31]  N. Borregaard,et al.  Neutrophils, from marrow to microbes. , 2010, Immunity.

[32]  R. Steinman,et al.  Microbial Stimulation Fully Differentiates Monocytes to DC-SIGN/CD209+ Dendritic Cells for Immune T Cell Areas , 2010, Cell.

[33]  T. Hibi,et al.  Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease. , 2010, Gastroenterology.

[34]  Z. Werb,et al.  Tumors as organs: complex tissues that interface with the entire organism. , 2010, Developmental cell.

[35]  O. Soehnlein,et al.  Phagocyte partnership during the onset and resolution of inflammation , 2010, Nature Reviews Immunology.

[36]  S. Gordon,et al.  Alternative activation of macrophages: mechanism and functions. , 2010, Immunity.

[37]  Jeffrey W. Pollard,et al.  Macrophage Diversity Enhances Tumor Progression and Metastasis , 2010, Cell.

[38]  Steffen Jung,et al.  Development of Monocytes, Macrophages, and Dendritic Cells , 2010, Science.

[39]  C. Weber,et al.  Mechanisms underlying neutrophil-mediated monocyte recruitment. , 2009, Blood.

[40]  G. Chejfec.  Robbins Pathologic Basis of Disease , 2009 .

[41]  G. Cheng,et al.  Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. , 2009, Cancer cell.

[42]  M. Neurath,et al.  STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing , 2009, The Journal of experimental medicine.

[43]  F. Martinon,et al.  The inflammasomes: guardians of the body. , 2009, Annual review of immunology.

[44]  A. Murphy,et al.  Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. , 2008, Immunity.

[45]  Michael S. Becker,et al.  Fate tracing reveals the endothelial origin of hematopoietic stem cells. , 2008, Cell stem cell.

[46]  R. Medzhitov.  Origin and physiological roles of inflammation , 2008, Nature.

[47]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[48]  G. Gerken,et al.  Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication. , 2008, Journal of hepatology.

[49]  L. Zon,et al.  Hematopoiesis: An Evolving Paradigm for Stem Cell Biology , 2008, Cell.

[50]  R. Xavier,et al.  IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. , 2008, The Journal of clinical investigation.

[51]  G. Barton,et al.  A calculated response: control of inflammation by the innate immune system. , 2008, The Journal of clinical investigation.

[52]  E. El-Omar,et al.  Polymorphisms in Toll-like receptor genes and risk of cancer , 2008, Oncogene.

[53]  G. Gerken,et al.  Toll‐like receptor‐mediated control of HBV replication by nonparenchymal liver cells in mice , 2007, Hepatology.

[54]  T. Tahara,et al.  Toll‐like receptor 2 –196 to 174del polymorphism influences the susceptibility of Japanese people to gastric cancer , 2007, Cancer science.

[55]  R. Medzhitov.  Recognition of microorganisms and activation of the immune response , 2007, Nature.

[56]  A. Cumano,et al.  Monitoring of Blood Vessels and Tissues by a Population of Monocytes with Patrolling Behavior , 2007, Science.

[57]  R. Medzhitov,et al.  Regulation of Spontaneous Intestinal Tumorigenesis Through the Adaptor Protein MyD88 , 2007, Science.

[58]  P. Viens,et al.  Cancer relapse under chemotherapy: why TLR2/4 receptor agonists can help. , 2007, European journal of pharmacology.

[59]  M. Olivier,et al.  Epstein-Barr Virus Induces MCP-1 Secretion by Human Monocytes via TLR2 , 2007, Journal of Virology.

[60]  H. Xiong,et al.  Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling. , 2007, Cancer research.

[61]  A. Krieg.  Development of TLR9 agonists for cancer therapy. , 2007, The Journal of clinical investigation.

[62]  E. El-Omar,et al.  A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. , 2007, Gastroenterology.

[63]  Judy H. Cho,et al.  A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene , 2006, Science.

[64]  Paolo Serafini,et al.  Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. , 2006, The Journal of clinical investigation.

[65]  Ruslan Medzhitov,et al.  Role of toll-like receptors in spontaneous commensal-dependent colitis. , 2006, Immunity.

[66]  J. Terzic,et al.  Microsatelite GT polymorphism in the toll‐like receptor 2 is associated with colorectal cancer , 2006, Clinical genetics.

[67]  R. Bataille,et al.  Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors , 2006, Leukemia.

[68]  S. Ménard,et al.  Antitumor Activity of the TLR-5 Ligand Flagellin in Mouse Models of Cancer1 , 2006, The Journal of Immunology.

[69]  T. Espevik,et al.  Toll-like receptors mediate proliferation and survival of multiple myeloma cells , 2006, Leukemia.

[70]  S. Lebecque,et al.  TLR3 Can Directly Trigger Apoptosis in Human Cancer Cells1 , 2006, The Journal of Immunology.

[71]  John Savill,et al.  Resolution of inflammation: the beginning programs the end , 2005, Nature Immunology.

[72]  R. Ferrero,et al.  Innate immune recognition of the extracellular mucosal pathogen, Helicobacter pylori. , 2005, Molecular immunology.

[73]  A. Mantovani,et al.  Smoldering and polarized inflammation in the initiation and promotion of malignant disease. , 2005, Cancer cell.

[74]  S. Akira,et al.  Papillomavirus-Like Particles Stimulate Murine Bone Marrow-Derived Dendritic Cells To Produce Alpha Interferon and Th1 Immune Responses via MyD88 , 2004, Journal of Virology.

[75]  R. Medzhitov,et al.  Regulation of Phagosome Maturation by Signals from Toll-Like Receptors , 2004, Science.

[76]  Irving L Weissman,et al.  Biology of hematopoietic stem cells and progenitors: implications for clinical application. , 2003, Annual review of immunology.

[77]  T. Ganz.  Defensins: antimicrobial peptides of innate immunity , 2003, Nature Reviews Immunology.

[78]  I. Mellman,et al.  Activation of Lysosomal Function During Dendritic Cell Maturation , 2003, Science.

[79]  K. Michelsen,et al.  Human Intestinal Epithelial Cells Are Broadly Unresponsive to Toll-Like Receptor 2-Dependent Bacterial Ligands: Implications for Host-Microbial Interactions in the Gut 1 , 2003, The Journal of Immunology.

[80]  C. Nathan.  Points of control in inflammation , 2002, Nature.

[81]  C. Funk,et al.  Prostaglandins and leukotrienes: advances in eicosanoid biology. , 2001, Science.

[82]  S. Akira,et al.  Toll-like receptors control activation of adaptive immune responses , 2001, Nature Immunology.

[83]  R. Schreiber,et al.  IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity , 2001, Nature.

[84]  R. Steinman,et al.  Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies. , 1999, Human immunology.

[85]  R. Steinman,et al.  Efficient Presentation of Phagocytosed Cellular Fragments on the Major Histocompatibility Complex Class II Products of Dendritic Cells , 1998, The Journal of experimental medicine.

[86]  Loise M. Francisco,et al.  Immature Dendritic Cells Phagocytose Apoptotic Cells via αvβ5 and CD36, and Cross-present Antigens to Cytotoxic T Lymphocytes , 1998, The Journal of experimental medicine.

[87]  P. Anthony,et al.  Chlamydia , 1990 .

[88]  H. Dvorak.  Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.

[89]  R. Steinman,et al.  Dendritic cells are accessory cells for the development of anti- trinitrophenyl cytotoxic T lymphocytes , 1980, The Journal of experimental medicine.

[90]  R. Steinman,et al.  Dendritic cells of the mouse: identification and characterization. , 1980, The Journal of investigative dermatology.

[91]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.

[92]  高山 哲朗.  Imbalance of NKp44[+]NKp46[-] and NKp44[-]NKp46[+] natural killer cells in the intestinal mucosa of patients with Crohn's disease , 2011 .

[93]  Richard N. Mitchell,et al.  Comprar Pocket Companion to Robbins & Cotran Pathologic Basis of Disease, 8th Edition | Jon Aster | 9781416054542 | Saunders , 2011 .

[94]  R. Medzhitov,et al.  Toll-like receptors and cancer , 2009, Nature Reviews Cancer.

[95]  L. Picker,et al.  Physiological and molecular mechanisms of lymphocyte homing. , 1992, Annual review of immunology.

[96]  F. Burnet.  The concept of immunological surveillance. , 1970, Progress in experimental tumor research.